E
Advanced Biomed Inc. ADVB
$0.71 $0.074211.67% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024
Total Cash And Short-Term Investments -- -4.30% 2.31% -0.55%
Total Receivables -- 25.63% 31.55% 36.80%
Inventory -- -- -- --
Prepaid Expenses -- 5.02% 7,015.15% 1,624.64%
Finance Division Loans and Leases Current -- -- -- --
Total Finance Division Other Current Assets -- -- -- --
Other Current Assets -- -- -- --
Total Current Assets -- -1.77% 12.63% 9.52%

Total Current Assets -- -1.77% 12.63% 9.52%
Net Property, Plant & Equipment -- -19.50% -28.73% -31.74%
Long-term Investments -- -- -- --
Goodwill -- -- -- --
Total Other Intangibles -- -73.20% -61.06% -52.46%
Finance Div Loans & Leases LT -- -- -- --
Total Finance Div Other LT Assets -- -- -- --
Total Other Assets -- 12.65% 7.90% 4.81%
Total Assets -- -5.74% 0.56% -3.04%

Total Accounts Payable -- 19.45% 4.46% -1.94%
Total Accrued Expenses -- 134.07% 19.60% -9.93%
Short-term Debt -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- --
Finance Division Debt Current -- 79.63% -68.80% -71.28%
Total Finance Division Other Current Liabilities -- -68.76% -51.98% -15.72%
Total Other Current Liabilities -- -68.76% -51.98% -15.72%
Total Current Liabilities -- -16.43% -9.16% -16.58%

Total Current Liabilities -- -16.43% -9.16% -16.58%
Long-Term Debt -- -- -- --
Short-term Debt -- -- -- --
Capital Leases -- -- 14,020.00% 243.09%
Finance Division Debt Non Current -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- --
Total Other Liabilities -- -- -- --
Total Liabilities -- -15.21% -7.24% -15.10%

Common Stock & APIC -- 20.60% 20.60% 20.60%
Retained Earnings -- -21.54% -16.30% -21.09%
Treasury Stock & Other -- 104.71% -23.76% 39.71%
Total Common Equity -- 214.53% 35.86% 27.40%

Preferred Stock Redeemable -- -- -- --
Preferred Stock Non Redeemable -- -- -- --
Preferred Stock Convertible -- -- -- --
Preferred Stock, Others -- -- -- --
Total Preferred Equity -- -- -- --

Total Common Equity -- 214.53% 35.86% 27.40%
Total Preferred Equity -- -- -- --
Total Minority Interest -- -- -- --
Total Equity -- 214.53% 35.86% 27.40%